Related Experiment Videos

Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity

L Gille1, H Nohl

  • 1Institute of Pharmacology and Toxicology, Veterinary University Vienna, Austria.

Insights

Adriamycin (AQ) cardiotoxicity involves heart mitochondria activating AQ via exogenous NADH dehydrogenase, leading to reactive oxygen species and impaired energy metabolism. This explains AQ

Area of Science:

  • Biochemistry
  • Cardiology
  • Toxicology

Background:

  • Adriamycin (AQ) cardiotoxicity's molecular basis remains unclear, though mitochondria are implicated.
  • Heart mitochondria, unlike liver mitochondria, activate AQ via electron transfer, forming reactive oxygen species.
  • Exogenous NADH dehydrogenase in heart mitochondria facilitates this electron deviation from the respiratory chain.

Purpose of the Study:

  • To elucidate the role of exogenous NADH dehydrogenase in adriamycin-induced cardiotoxicity.
  • To analyze the radical species formed and their impact on cardiac energy metabolism.
  • To understand the selective cardiotoxic potency of anthraquinone glycosides.

Main Methods:

  • Electron Spin Resonance (ESR) technique was used to analyze radical species.
  • Isolated heart and liver mitochondria were utilized to compare AQ activation pathways.
  • NADH was used as a substrate to investigate electron flux.

Main Results:

  • Heart mitochondria, in the presence of NADH, shuttle electrons to AQ, generating O2.-.
  • Exogenous NADH dehydrogenase is crucial for this electron transfer and AQ activation in heart mitochondria.
  • AQ activation leads to the formation of lipophilic aglycone metabolites, disrupting mitochondrial function and energy production.

Conclusions:

  • Exogenous NADH dehydrogenase plays a key role in adriamycin cardiotoxicity by initiating a pathway of oxygen activation.
  • The formation of reactive oxygen species and disruption of energy metabolism by AQ metabolites contribute to heart injury.
  • This mechanism explains the selective cardiotoxicity of anthraquinone glycosides in cardiac tissue.

Related Concept Videos